Woman with Alzheimer's begins 3,000-mile walk to raise awareness
Thirteen years after her Alzheimer's diagnosis, a California woman is more vibrant than ever — and she has just embarked on a walk across America to showcase the power of action in healthy aging.
Judy Benjamin, PhD, now 80 years old, set off on Saturday, April 5, on a 3,000-mile journey across the country.
Over five months, she will walk from San Diego, California, to St. Augustine, Florida.
"People wonder why would I put myself through this," Benjamin said during an on-camera interview with Fox News Digital the evening before her walk began. "I really want to share with others not to be discouraged."
"Life is here to enjoy, and age is a number, but you don't have to be identified and characterized by that number."
Benjamin was 67 when she first learned of her early-onset Alzheimer's disease.
It wasn't a surprise, as she comes from a long line of relatives who were affected by that form of dementia. Her mother, one of 13 children, was 63 when she was diagnosed, and nine of her uncles also got it.
"So obviously it was very scary for me," Benjamin said during an on-camera interview with Fox News Digital the evening before her walk began.
After her mother passed away, Benjamin — who had a high-pressure job at the time — started getting symptoms.
"I was working overseas and started to get really worried because I couldn't remember things — even my own phone number or locker combination," she recalled. "I got lost driving, when I'm always really good about direction."
Benjamin also started to struggle to remember her grandchildren's names, and even had trouble reading a newspaper article.
"I knew that it was going downhill really quickly, and I was extremely depressed and distressed about that," she recalled.
"Life is here to enjoy, and age is a number, but you don't have to be identified and characterized by that number."
Brain scans showed that Benjamin had a lot of amyloid plaque, as well as some damage to the right and left parietal areas of her brain.
"I started to get really panicked," she said.
A close friend recommended a doctor in California, Dr. Dale Bredesen, who was doing some innovative research on treating Alzheimer's.
"He explained his theory that Alzheimer's is not caused by one thing — it's a number of different assaults on the brain, which causes it to become inflamed," she said. "And he said it was different for everybody. Some people are more affected by some things than others."
Bredesen worked with Benjamin to help her reduce the inflammation through a number of steps.
"So I wrote down what he recommended, and I flew back home and I started implementing it to the letter — I changed my whole lifestyle," she shared.
Some of those lifestyle changes involved optimizing her sleep, ensuring healthy indoor air, incorporating meditation to reduce stress and starting an exercise routine.
"I also totally changed my diet," Benjamin shared. "I stopped drinking diet soda, stopped eating sugar, and started eating more whole foods and natural foods — like vegetables and fruit."
"It's super important to follow all of the instructions to do what you need to do, and not be casual about it."
Gradually, she said, things started to change.
"It wasn't overnight; it's not a magic bullet," she said. "But I realized one day that I could remember my grandchildren's names again."
After seeing firsthand the positive effects of her new lifestyle, Benjamin felt compelled to help others. She ultimately became a national board-certified health and wellness coach, specializing in brain health and neurology.
Benjamin said she has been doing longer walks to prepare for her 3,000-mile walk.
"I think there's really no way to train for a 3,000-mile walk, except walk as much as you can," she said. "I think walking is the most natural thing that a human being can do. I mean, we were born to walk."
"I just have to be careful to keep hydrated."
Benjamin will be joined on her cross-country walk by a "great support team" as well as a film crew who will gather footage for an upcoming documentary.
"I do have an RV with a very comfortable bed, shower and cooking facilities," she said. "Whenever possible, if there's a nice hotel or motel, we'll stop, but in the long, remote stretches, we'll be sleeping in the RV."
She is also supported by several wellness sponsors, including Apollo Health and CareScouts, a provider of long-term care and aging solutions.
The goal is to shoot for 20 miles per day, depending on the weather and terrain.
"I will plan on stopping one day a week to rest my body, maybe take a sauna or just kick back," she said.
"It's pretty much me as an individual, but I am encouraging people to come and join me and walk with me."
Today, at 80, Benjamin said she feels younger than she did before her Alzheimer's diagnosis.
"I'm very energetic and healthy — I have great flexibility and I do have confidence that I will continue to be healthy," she told Fox News Digital.
That said, she added, life is "kind of like a crapshoot."
"Anything can happen — I'm very aware of that, but all my numbers are great. My blood work, my bone studies, everything is in such good shape that I'm not really worried. I don't spend much time on the negative."
Benjamin hopes that her walk will serve as motivation for others to embrace healthier, more active lifestyles for better brain function.
"I want people to see that no matter your age or circumstances, there are steps you can take to live a healthier, more vibrant life."
"When I received my diagnosis, I had a choice — I could let it define me, or I could take action," she said.
"I want people to see that, no matter your age or circumstances, there are steps you can take to live a healthier, more vibrant life. This walk is about proving that possibility."
For more Health articles, visit www.foxnews.com/health
People can follow Benjamin's journey at Judywalks.com, @judywalksamerica on Instagram, Facebook, TikTok and YouTube; and on CareScout's Facebook or LinkedIn pages.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
13 hours ago
- Business Wire
IHI Appoints Sylvia Trent-Adams President and CEO
BOSTON--(BUSINESS WIRE)--The Institute for Healthcare Improvement (IHI) today announced that Sylvia Trent-Adams, PhD, RN, FAAN, FNAP, ANEF will become the organization's President and CEO effective July 14, 2025. Dr. Trent-Adams is a distinguished health care leader and public health advocate who has dedicated her career to improving health and health care in the US and around the world. 'It is a true honor to accept the position of President and CEO of IHI – an organization that I view as a global powerhouse for quality improvement, patient safety, and health equity,' said Dr. Trent-Adams. 'I believe we're at an inflection point both domestically and abroad, and IHI is positioned to be a change agent and a force for good in health and health care worldwide. I look forward to working with IHI staff, leadership, and our coalition of partners to move forward in service of our mission.' 'Sylvia has held many titles during her impressive career – nurse, soldier, researcher, Rear Admiral, Acting Surgeon General, university President – and we're thrilled that she's adding 'IHI President and CEO' to that list,' said Gerald Hickson, MD, IHI Board Chair. 'We've had the honor of working closely with Sylvia since she joined IHI's board of directors three years ago and know her to be a person of strong character, humility and integrity, an experienced health care leader, and a passionate advocate for safety and quality improvement.' Dr. Trent-Adams will succeed Kedar Mate, MD, who stepped down as IHI's President and CEO in December 2024 to establish a new venture in the health care AI space. Since that time, Chief Operating Officer, Melissa Panagides-Busch, has served as both COO and Interim CEO. She will return to her full-time role as COO when Dr. Trent-Adams begins her tenure as President and CEO. The board is grateful to Ms. Panagides-Busch for her steady leadership during this time of transition. A lifelong public servant, Dr. Trent-Adams served for more than 30 years in the US Army and US Public Health Service Commissioned Corps (USPHS). This included service as Deputy Surgeon General and Acting Surgeon General – roles in which she combined scientific rigor, trusted leadership, and a focus on equity to protect and improve the health of all Americans. As US Department of Health & Human Services (HHS) Principal Deputy Assistant Secretary for Health, she led numerous national and global public health initiatives, directed HHS-wide public health policies and programs, and managed national public health response efforts. Most recently, Dr. Trent-Adams served as President of the University of North Texas Health Science Center (UNTHSC). During her tenure at the university, UNTHSC was awarded a $150 million grant to research Alzheimer's disease, the largest grant in the UNT system's history. Dr. Trent-Adams also oversaw the launch of a new College of Nursing at UNTHSC. Dr. Trent-Adams has significant experience on the global stage, which will be an asset to IHI staff, partners, and customers around the world. She led HIV/AIDS initiatives in Sub-Saharan Africa, and she was the first commanding officer on the ground in Monrovia, Liberia, leading the Commission Corps Ebola response. She also represented the US at the World Health Organization's Global Nursing Forum, where she advocated for nursing and public health policies that advance equitable care worldwide. 'The board of directors has full confidence that under Sylvia's leadership, IHI will build on its legacy of impact – advancing the science of improvement, improving systems and outcomes at scale, and shaping the future of health and health care worldwide,' concluded Hickson. The Institute for Healthcare Improvement (IHI) is a leading, globally recognized not-for-profit health care improvement organization that has been applying evidence-based quality improvement methods to meet current and future health care challenges for more than 30 years. IHI provides millions of people in health care with methods, tools, and resources to make care better, safer, and more equitable; convenes experts to enable knowledge sharing and peer-learning; and advises health systems and hospitals of all sizes in improving their systems and outcomes at scale. IHI's mission is to innovate and lead transformational improvement in health and health care worldwide.
Yahoo
17 hours ago
- Yahoo
Why a database of bug genes could be one of Trump's most devastating cuts at Harvard
For decades, scientists have gleaned information from the antennae, brains and even ovaries of millimeter-sized fruit flies for medical research as varied as Alzheimer's, Parkinson's, addiction, traumatic brain injuries, birth defects and nerve regeneration. But President Donald Trump's sweeping biomedical research cuts at Harvard University threaten the world's only repository of that data. The free website FlyBase, considered the 'Wikipedia of fruit fly research' among scientists worldwide, is a project under Harvard's stewardship. It recently saw its funding terminated by the National Institutes of Health. 'There really isn't a second version of what we do,' said Victoria Jenkins, a genome database coordinator at Harvard's Department of Molecular and Cellular Biology. 'We are the one resource for this information.' Read more: 'Devastating': 10 Harvard researchers detail 'essential' work set to be cut by Trump The reason why a database containing information about every fruit fly (or Drosophila) gene and genome is so important? The bug typically associated with rotting fruits and vegetables happens to share nearly 70% of its DNA structure with humans, making them ideal test subjects in many cases, researchers say. Discoveries fueled by fruit fly research have been honored by the Nobel Prize six times, dating back to 1933. The May termination of FlyBase's NIH grant puts at risk the future of the project, containing 32 years worth of data. 'There are a lot of unexpected places that very common, big discoveries come from,' fruit flies included, Jenkins said. Jenkins is one of the people who keeps FlyBase, a partnership between four universities, running. She extracts, interprets and archives data to make it accessible to the public and other researchers. Before working with FlyBase, Jenkins did hands-on research with fruit flies, looking at their genes involved in stem cell regulation. Using carbon dioxide, she would anesthetize them on a plate in order to physically handle them. Read more: Harvard researcher's work gives 'hope' for Parkinson's. But the feds cut his funding Susan Russo, the program director of FlyBase who is based at Harvard, said bone morphogenetic proteins — which help form bone and cartilage — were understood using fruit flies, 'and flies don't even have bones.' 'People say, why a fruit fly? It's a model organism that's used before clinical trials for human diseases,' Russo said. 'It's basic science and translational investigations — ultimately things that go to clinical trials. It's been critical for human disease.' FlyBase is a multi-university partnership between Harvard, Indiana University Bloomington, University of New Mexico and University of Cambridge in the United Kingdom. Because Harvard was the NIH grant awardee, the termination ceased funding for all of the involved entities. Now, researchers are seeking financial support elsewhere to preserve the website as is — at the very least. The European researchers are fundraising across the pond, while the U.S.-based operations work on their own mechanisms to collect emergency dollars. Read more: Trump cuts threaten 'irreplaceable' Harvard stockpile of human feces, urine Both Jenkins and Russo claimed FlyBase's association with Harvard was the central reason why it's funding was cut. Pressuring the elite university to change its policies and surrender sensitive data in the name of antisemitism, the Trump administration has inundated Harvard with a barrage of funding and grant revocations, as well as actions trying to stop its ability to enroll international students. Last week, Trump said his administration could be nearing a deal with Harvard, but few details are currently known. Harvard is also actively suing the administration in two separate federal court lawsuits. In a statement, NIH told MassLive that all federal funds to Harvard currently remain paused as part of the administration's multi-agency Task Force to Combat Anti-Semitism. The agency cited Trump's executive order on 'Additional Measures to Combat Anti-Semitism,' related to rooting out antisemitism on college campuses. 'NIH remains committed to supporting high-quality, taxpayer-funded science — free from ideological agendas and political bias,' the agency said. 'If Harvard meets the standards set by the Administration, FlyBase investigators will regain access to funding and will be able to continue their important work in advancing biomedical research.' Jenkins, whose entire salary is funded by the federal government, called fruit fly research 'incredibly cost-effective,' making the grant revocation all the more frustrating. 'Flies are inexpensive,' she said. 'They're easy to work with, easy to get started, and they don't have a lot of the ethical concerns associated with other animals. The amount of work you can do is so much easier.' A Nobel Prize in Physiology or Medicine was awarded to fruit fly research as recently as 2017 for 'the discovery of molecular mechanisms controlling the circadian rhythm.' Using fruit flies as models, the researchers were able to isolate a gene that controls the normal daily biological rhythm. Liqun Luo, a professor of biology at Stanford University, recently told The Transmitter, a neuroscience online publication, 'it would be a disaster' if FlyBase 'goes dark.' According to its NIH grant description, FlyBase enables more than 4,000 research laboratories to further their work. While Harvard announced in May it would dole out $250 million as a stopgap for its researchers facing funding cuts, its FlyBase employees don't know yet if they'll be eligible. The immediate goal, Jenkins and Russo said, is to capture the database as is so they can ultimately migrate it over to a larger website initiative funded by the National Human Genome Research Institute. When complete, that website will consolidate genetic model organism data — including worms, zebrafish, rats and fruit flies — in one place. Harvard Kennedy's backup plan for foreign students: Study online, or in Canada Judge rules Trump can't invoke national security powers to ban foreign Harvard students Harvard's Jewish faculty have their own wish list for a deal with Trump These 16 states are supporting the Trump admin in lawsuit with Harvard Read the original article on MassLive.
Yahoo
17 hours ago
- Yahoo
INmune Bio's Alzheimer's drug falls short of mid-stage study goal, shares tumble
(Reuters) -INmune Bio said on Monday its experimental Alzheimer's drug failed to improve cognitive functions in patients with early stages of the mind-robbing disease in a mid-stage study, sending its shares plunging nearly 63% in premarket trading. The drug, XPro, is designed to target and inhibit inflammatory signals associated with a type of protein called tumor necrosis factor without suppressing the immune system. The study enrolled 208 patients with mild Alzheimer's disease (AD), or mild cognitive impairment, an early sign of the disease, who were randomly chosen to receive a weekly subcutaneous injection of XPro or a placebo for 24 weeks. The drug was safe and well-tolerated, the company said, with injection site reactions the most common adverse event. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
